Concepedia

Mark K. Ogawa

MK

Statistics

Publications

4

Citations

209

H-Index

4

Active since

1978

Affiliations

Kindeva Drug Delivery (United States)(Current)

Mark K. Ogawa is an author at Kindeva Drug Delivery (United States) specializing in pyrimidine chemistry, pyrimidine analogs, and chemistry.

Publications per year

1978–2012

4

Publications

4

C-5 substituted pyrimidine nucleosides. 2. Synthesis via olefin coupling to organopalladium intermediates derived from uridine and 2'-deoxyuridine

Donald E. Bergstrom, Mark K. Ogawa · Journal of the American Chemical Society · 1978 · 101 citations

Natural Sciences, Chemistry, Bioorthogonal Chemistry +9

Antiviral activity of C-5 substituted tubercidin analogs

Donald E. Bergstrom, Alan J. Brattesani, Mark K. Ogawa et al. · Journal of Medicinal Chemistry · 1984 · 75 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Pyrrolo[2,3-d]pyrimidine nucleoside antibiotic analogs. Synthesis via organopalladium intermediates derived from 5-mercuritubercidin

Donald E. Bergstrom, Alan J. Brattesani, Mark K. Ogawa et al. · The Journal of Organic Chemistry · 1981 · 23 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12

Forced Degradation Studies of Corticosteroids With an Alumina–Steroid–Ethanol Model for Predicting Chemical Stability and Degradation Products of Pressurized Metered-Dose Inhaler Formulations

Zhengzhi Wu, Matthew L. Thatcher, James K. Lundberg et al. · Journal of Pharmaceutical Sciences · 2012 · 10 citations

Pharmacy, Pharmaceutics, Pharmacology +17

1–4 of 4